Abstract
Nails abnormalities can be readily examined by dermatologists and may be the first indication that there is an underlying systemic disease. Splinter hemorrhages are usually due to trauma, but subacute bacterial endocarditis is another possible cause. Leukonychia is more specifically associated with systemic disease, and examples include half and half nails, Terry’s nails, and Muehrke’s lines. In yellow nail syndrome, there is a classic triad of thick and yellow nails with increased transverse curvature, absent cuticles, and slow growth rate, as well as, lymphedema, and respiratory tract involvement. Nails changes are common in pregnancy, specifically increased transverse curvature, and brittleness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemec GB, Kollerup G, Jensen LB, Morgensen S. Nail abnormalities in nondermatologic patients: prevalence and possible role as diagnostic aids. J Am Acad Dermatol. 1995;32:977–81.
Dupond AS, Magy N, Humbert P, Dupond JL. Manifestations ungueales des maladies generales. La Revue du Practicien. 2000;50:2236–40.
Zaias N. The nail in health and disease. New York: Spectrum Publications; 1980.
Daniel CR, Daniel MP. Nail signs of systemic disease. Consultant. 1995;35:392.
Daniel CR. Nails in systemic disease. Audiotape presented at the meeting of the American Aca demy of Dermatology, New Orleans. 1995.
Daniel CR, Scher RI. The nail. In: Sams WM, Lynch PJ, editors. Principles and practice of dermatology. 2nd ed. New York: Churchill-Livingstone; 1996. p. 763–77.
Kilpatrick ZM, Greenberg PA, Sanford JP. Splinter hemorrhages – their clinical significance. Arch Intern Med. 1965;115:730.
Blum M, Avinam AL. Splinter hemorrhages in patients receiving regular hemodialysis. JAMA. 1978;239:44.
Fitzpatrick TB. Dermatology in general medicine. 2nd ed. New York: McGraw-Hill; 1979.
Samman PD. The nails in disease. 3rd ed. Chicago: Year Book; 1978.
Zaias N. The nail in health and disease. New York: Spectrum Publications; 1980. citing Alkiewicz J. Zur Histopathologie der Hamatome des Menschlichen Nagels. Arch Dermatol Syphilol 1033; 168:411
Moschella SL, Hurley HJ, editors. Cutaneous manifestations of immunodeficiency in dermatology. 2nd ed. Philadelphia: WB Saunders; 1985. p. 218.
Cohen PR, Scher RI. Geriatric nail disorders: diagnosis and treatment. J Am Acad Dermatol. 1992;26:521.
Norton L. Determining if subungual bleeding signals systemic disease, trauma. Skin Allergy News. 1991;22:5.
Tosti A, Baran R, Dawber RPR. The nail in systemic diseases and drug-induced changes. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 2nd ed. Oxford: Blackwell Scientific; 1994. p. 175–261.
Penas PF, Porras JI, Fraga J, et al. Microscopic polyangiitis. A systemic vasculitis with a positive P-ANCA. Br J Dermatol. 1996;134(3):542–7.
De Barber D. What do Beau’s lines mean. Int J Dermatol. 1994;33:545.
Baran R, Dawber RPR. Disease of the nails and their management. 2nd ed. Oxford: Blackwell Science; 1994.
Baran R, Dawber RPR. Physical signs. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 2nd ed. Oxford: Blackwell Scientific; 1994. p. 35–80.
Bernier V, Labreze C, Bury F, Taieb A. Nail matrix arrest in the course of hand, foot and mouth disease. Eur J Pediatr. 2001;160:649–51.
Clementz GC, Mancini AJ. Nail matrix arrest following hand-foot mouth disease: a report of five children. Pediatr Dermatol. 2000;17:7–8.
Tosti A, Piraccini BM. Onychomadesis and pyogenic granuloma following cast immobilization. Arch Dermatol. 2001;137:231–2.
Lewin K. The fingernail in general disease. Br J Dermatol. 1965;77:431.
DeNicola P, Morsiani M, Zavagli G. Nail diseases in internal medicine. Springfield: Charles C Thomas; 1974.
Daniel CR. Onycholysis: an overview. Semin Dermatol. 1991;10:34.
Degowin EL, Degowin RL. The nails in bedside diagnostic examination. 2nd ed. New York: Macmillan; 1969.
Luria MN, Asper SP. Onycholysis in hyperthyroidism. Ann Intern Med. 1958;49:102.
Lavoy MR, Gluhm GB, Morales A. The occurrence of nail pitting in Reiter’s syndrome. J Am Acad Dermatol. 1980;2:66.
Pajarre R, Kemo M. Nail changes as the first manifestation of HLA B27 inheritance. Dermatologica. 1977;154:350.
Urowitz M, Gladman DD, Chalmers A, et al. Nail lesions in systemic lupus erythematosus. J Rheumatol. 1978;5:441.
Dupre A, Viraben R, Bonafe JL, et al. Zebra-like dermatomyositis. Arch Dermatol. 1981;117:63.
Patel KB, Sharma OP. Nail in sarcoidosis: response to treatment. Arch Dermatol. 1983;119:277.
Baumal A, Robinson MJ. Nail bed involvement in pemphigus vulgaris. Arch Dermatol. 1973;107:751.
Stone OJ. Spoon nails and clubbing. Cutis. 1975;16:235.
Stone OJ, Maberry JD. Spoon nails and clubbing. Tex State J Med. 1965;61:620.
Jalili MA, Al-Kassaf S. Koilonychia and cystine content of nails. Lancet. 1959;i:108.
Bentley-Phillips B, Bayles MA. Occupational koilonychia of the toenails. Br J Dermatol. 1971;85:140.
Baran R. Nail changes in general pathology. In: Pierre M, editor. The nail. New York: Churchill Livingstone; 1981. p. 5–105.
Runne U, Orfanos CE. The human nail. In: Mali WH, Karger S, editors. Current problems in dermatology, vol. 9. Basel: S Karger; 1981. p. 102–49.
Bergeron JR, Stone OJ. Koilonychia: a report of familial spooned nails. Arch Dermatol. 1967;95:351.
Baran R, Achten G. Les associations congenitales de koilonychia et de leuconychie totale. Arch Beiges Syphiligr. 1969;25:13.
Hordinsky MK. Hair. In: Sams M, Lynch P, editors. Principles and practice of dermatology. New York: Churchill Livingstone; 1990. p. 761–80.
Cohen PR, Prystowsky JH. Metabolic and nutritional disorders. In: Sams W, Lynch P, editors. Principles and practice of dermatology. New York: Churchill-Livingstone; 1990. p. 665–81.
Daniel CR, Osment LS. Nail pigmentation abnormalities, their importance and proper examination. Cutis. 1980;25:595.
Takeuchi Y, Iwase N, Suzuki M, Tsuyuki S. Lichen planus with involvement of all twenty nails and the oral mucous membrane. J Dermatol. 2000;27:94–8.
Claude CD, Zic JA, Boyd AS. Idiopathic leukonychia totalis and partialis in a 12-year-old patient. J Am Acad Dermatol. 2001;44:379–80.
Foti C, et al. Transverse leukonychia in severe hypocalcemia. Eur J Dermatol. 2004;14:67–8.
Marcilly MC, et al. Sub-total hereditary leukonychia, histopathology and electron microscopy study of ‘milky’ nails. Ann Dermatol Venereal. 2003;130:50–4.
Hudson JB, Dennis AJ Jr. Transverse white lines in the fingernails after acute and chronic renal failure. Arch Intern Med. 1976;117:276.
Pardo-Castello V. Diseases of the nails. 3rd ed. Springfield: Charles C Thomas; 1960.
Conn RD, Smith RH. Malnutrition, myoedema Muehrcke’s lines. Arch Intern Med. 1965;116:875.
Muehrcke RC. The fingernails in chronic hypoalbuminemia. Br Med J. 1956;1:327.
Schwartz RA, Vickerman CE. Muehrcke’s lines of the fingernails. Arch Intern Med. 1979;139:242.
Feldman SR, Gummon WR. Unilateral Muehrcke’s lines following trauma (letter). Arch Dermatol. 1989;125:133.
Alam M, Scher RK, Bickers DR. Muehrcke’s lines in a heart transplant recipient. J Am Acad Dermatol. 2001a;44:316–7.
Nabai H. Nail changes before and after heart transplantation: personal observation by a physician. Cutis. 1998;61:31–2.
Ruggeri S, Viviano MT, Papi M, et al. Seasonal leukonychia: microvascular alteration? Eur Acad Dermatol Venereol. 2000;14(Suppl 1):113.
Daniel CR III, Bower JD, Daniel CR Jr. The half and half fingernail: the most significant onychopathological indicator of chronic renal failure. J Miss State Med Assoc. 1975;16:376.
Daniel CR III, Bower JD, Daniel CR Jr. The half and half fingernail: a clue to chronic renal failure. Proc Clin Dial Transplant Forum. 1975;5:1.
Lubach D, Strubbe I. The frequency of subungual erythema. Z Hautkr. 1982;57:1486.
Terry R. White nails in hepatic cirrhosis. Lancet. 1954;i:757–9.
Holzberg M, Walker HK. Terry’s nails: revised definition and new correlations. Lancet. 1984;i:896–9.
Terry RB. The onychodermal band in health and disease. Lancet. 1955;i:179.
Daniel CR. The nail. In: Sams M, Lynch P, editors. Principles and practice of dermatology. New York: Churchill Livingstone; 1990. p. 743–60.
Lovibond JL. Diagnosis of clubbed fingers. Lancet. 1938;i:363.
Goyal S, Griffiths AD, Omarouayache S, et al. An improved method of studying fingernail morphometry: application to the early detection of clubbing. J Am Acad Dermatol. 1998;39:640–2.
Brickman AS. Grand rounds: progressive shortening of the fingertips. Drug Ther. 1981;49.
Mendlowitz M. Measurements of blood flow and blood pressure in clubbed fingers. J Clin Invest. 1941;20:113.
Hall GH. The cause of digital clubbing. Lancet. 1959;i:750.
Bashour FA. Clubbing of the digits: physiologic considerations. J Lab Clin Med. 1961;58:613.
Ginsberg J, Brown JB. Increased estrogen exertion in hypertrophic pulmonary osteoarthropathy. Lancet. 1961;ii:1274.
Mackie RM. Lupus erythematosus in association with finger clubbing. Br J Dermatol. 1973;89:533.
Davis GM, Rubin J, Bauer JD. Digital clubbing due to secondary hyperparathyroidism. Arch Intern Med. 1990;150:452.
Scherbenske JM, Benson PM, Rotchford JP, James WD. Cutaneous and ocular manifestations of Down syndrome. J Am Acad Dermatol. 1990;22:933.
West SG, Gilbreath RE, Lawless OJ. Painful clubbing and sarcoidosis. JAMA. 1981;246:1338.
Braverman IM. Skin signs of systemic disease. 2nd ed. Philadelphia: WB Saunders; 1981.
Pines A, Olchovsky D, Bregman J, et al. Finger clubbing associated with laxative abuse. South Med J. 1983;76:1071.
Burgdorf W. Cutaneous manifestations of Crohn’s disease. J Am Acad Dermatol. 1981;5:689.
Demis DJ, editor. Clubbing of the fingers in clinical dermatology, vol. 1. New York: Harper & Row; 1980.
Brenner S, Srebrnik A, Kisch ES. Pachydermoperiostosis with new clinical and endocrinologic manifestation. Int J Dermatol. 1992;31:341.
Just-Viera JO. Clubbed digits: an enigma. Arch Intern Med. 1964;113:122.
Terry R. Red half -moons in cardiac failure. Lancet. 1954;ii:842.
Jeremias FJ, Sole MD, Conti M, Camarasa JG. Sindrome de las unas amarillas asociado a miocardiopatia. Med Cutan Iber Lat Am. 1996;24:279–82.
Barone SR, et al. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection. Arch Pediatr Adolesc Med. 2000;154:453–6.
Dhawan SS, Zaias N, Pena J. The nail fold in pemphigus vulgaris. Arch Dermatol. 1990;126:1374.
Garg RK. Determination of ABOCH blood group-specific substances from fingernails. Am J Forensic Med Pathol. 1983;4:143.
Samman PD. Management of disorders of the nails. Clin Exp Dermatol. 1982;7:189.
Beam AG, McKusick VA. Azure lunulae. JAMA. 1958;166:904.
Mathias CGT, Caldwell TM, Maibach HI. Contact dermatitis and gastrointestinal symptoms from hydroxyethylomethacrylate. Br J Dermatol. 1979;100:447.
Greene RA, Scher RK. Nail changes associated with diabetes mellitus. J Am Acad Dermatol. 1987;16:1015.
Feingold KR, Elias PM. Endocrine-skin interactions. J Am Acad Dermatol. 1987;17:921.
Bissell GW, Sarakomoi K, Greenslit F. Longitudinal banded pigmentation of nails in primary adrenal insufficiency. JAMA. 1971;215:1656.
Scher RK, Bodian AB. Brittle nails. Semin Dermatol. 1991;10:21.
Scher RK. Brittle nails. Int J Dermatol. 1989;28:515.
Rook A, Wilkinson DS, Eblins FJG, et al. Textbook of dermatology. 3rd ed. Oxford: Blackwell Scientific; 1979.
Baran R, Dawber RPR. Diseases of the nails and their management. Oxford: Blackwell Scientific; 1984.
Moschella SL, Pillsbury DM, Hurley HJ. Dermatology. Philadelphia: WB Saunders; 1975.
Patki AH, Mehta JM. Pterygiumunguium in a patient with recurrent type 2 lepra reaction. Cutis. 1989;44:311.
Menter MA, Morrison JGL. Lichen verrucosus et reticularis of Kaposi: a manifestation of acquired adult toxoplasmosis. Br J Dermatol. 1976;94:645.
Hirschmann JV. Cutaneous signs of systemic bacterial infection. In: Sams WM, Lynch PJ, editors. Principles and practice of dermatology. New York: Churchill-Livingstone; 1990. p. 89–98.
Allen LA. Occult blood accumulation under the fingernails: a mechanism for the spread of blood-borne infection. J Am Acad Dermatol. 1982;105:455.
Scher RK. Subungual scabies. Am J Dermatopathol. 1983;5:187.
Witkowski JA, Parish LC. Scabies, subungual areas harbor mites. JAMA. 1984;252:1318.
Kosinski MA, Stewart D. Nail changes associated with systemic disease and vascular insufficiency. Clin Podiatr Med Surg. 1989;6:295.
Daniel CR, Norton LA, Scher RI. The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27:93.
Daniel CR. Nail disease in patients with HIV infection. In: Burgdorf WHC, Katz SI, editors. Dermatology, progress and perspectives: the proceedings of the 18th world congress of dermatology. New York: Parthenon; 1993. p. 382–5.
Cribier B, et al. Nail changes in patients infected with human immunodeficiency virus. Arch Dermatol. 1998;134:1216–20.
Dompmartin D, Dompmartin A, Deluol AM, et al. Onychomycosis and AIDS: clinical and laboratory findings in 62 patients. Int J Dermatol. 1990;29:337.
Kaplan MH, Sadick N, McNutt NS, et al. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol. 1987;16:485.
Lizama E, Logemann H. Proximal white subungual onychomycosis in AIDS. Int J Dermatol. 1996;35:290.
Rongioletti F, Persi A, Tripodi S, Rebora A. Proximal white subungual onychomycosis: a sign of immunodeficiency. J Am Acad Dermatol. 1994;30:129.
Elewski BE. Clinical pearl: proximal white subungual onychomycosis in AIDS. J Am Acad Dermatol. 1993;29:631.
Haley L, Daniel CR. Fungal infection of the nails. In: Scher RK, Daniel CR, editors. Nails: therapy, diagnosis, surgery. Philadelphia: WB Saunders; 1990. p. 106–19.
Daniel CR, Elewski BE. Candida as a nail pathogen in healthy patients. J Miss State Med Assoc. 1995;36:379–81.
Scher RK. Nail signs of systemic diseases (audiotape). Dialogues Dermatol. 1991;28.
Fisher BK, Warner LC. Cutaneous manifestations of the AIDS: update 1987. Int J Dermatol. 1987;26:615.
Montemarano AD, Benson PM, James WD, Croup MA. Acute paronychia apparently caused by Candida albicans in a healthy female. Arch Dermatol. 1993;129:786.
Prose NS. HIV infection in children. J Am Acad Dermatol. 1990;22:1223.
Prose NS, Abson KG, Scher RK. Disorders of the nails and hair associated with HIV infection. Int J Dermatol. 1992;31:453.
Valenzano L, Giacalone B, Grillo LR, Ferraris AM. Compromissione ungueale in corso di AIDS. G Ital Dermatol Venereal. 1988;123:527.
Daniel CR. The diagnosis of nail fungal infection. Arch Dermatol. 1991;127:1566.
Straka BP, Whitaker DL, Morrison SH, et al. Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol. 1988;18:1089.
Eliezri Y, Silverstein SJ, Nuara GJ. Occurrence of human papilloma virus type 16 DNA in cutaneous squamous and basal cell carcinomas. J Am Acad Dermatol. 1990;23:836.
Rau RC, Baird IM. Crusted scabies in a patient with acquired immunodeficiency syndrome (letter). J Am Acad Dermatol. 1986;15:1058.
Drabick JJ, Lupton GP, Tompkins K. Crusted scabies in human immunodeficiency virus infection (letter). J Am Acad Dermatol. 1987;17:142.
Depaoli RT, Marks VJ. Crusted (Norwegian) scabies: treatment of nail involvement (letter). J Am Acad Dermatol. 1987;17:136.
Scher RK. Subungual scabies (letter). Am J Dermatopathol. 1983;5:187.
High WA, Tyring SK, Taylor RS. Rapidly enlarging growth of the proximal nail fold. Dermatol Surg. 2003;29:984–6.
Kaplan MH, Sadick NS, Wieder J, et al. Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis. J Am Acad Dermatol. 1989;20:76.
Rasokat H. Psoriasis in AIDS: remission with high dosage cotrimoxazole. A Hautkr. 1986;61:991.
Marcusson JA, Wetterberg L. Peptide-T in the treatment of AIDS associated psoriasis and psoriatic arthritis. Acta Derm Venereal (Stockh). 1989;69:86.
Rosenberg EW, Noah D, Skinner RB. AIDS and psoriasis. Int J Dermatol. 1991;30:449.
Belz J, Breneman DL, Nordlund JJ, Solinger A. Successful treatment of a patient with Reiter’s syndrome and acquired immunodeficiency syndrome using etretinate. J Am Acad Dermatol. 1989;20:898.
Bluvelt A, Nahass GT, Pardo RJ, et al. Pityriasis rubra pilaris and HIV infection. J Am Acad Dermatol. 1991;24:703.
Cohen S, Dicken CH. Generalized lichen spinulosus in an HIV positive man. J Am Acad Dermatol. 1991;25:116.
Daniel CR, Sams WM, Scher RI. Nails in systemic disease. In: Scher RK, Daniel CR, editors. Nails: therapy, diagnosis, surgery. 2nd ed. Philadelphia: WB Saunders; 1990. p. 167–91.
Chernosky ME, Finley VK. Yellow nail syndrome in patients with acquired immunodeficiency disease. J Am Acad Dermatol. 1985;13:731.
Daniel CR. Yellow nail syndrome and acquired immunodeficiency disease. J Am Acad Dermatol. 1986;14:844.
Norton AL. Yellow nail syndrome controlled by vitamin E therapy (letter). J Am Acad Dermatol. 1986;15:715.
Scher RK. Acquired immunodeficiency syndrome and yellow nails (letter). J Am Acad Dermatol. 1988;18:758.
Goodman DS, Teplitz E, Wishner A, et al. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol. 1987;17:210.
Daniel CR, Scher RK. Nail changes secondary to systemic drugs or ingestants. In: Scher RK, Daniel CR, editors. Nails: therapy, diagnosis, surgery. 2nd ed. Philadelphia: WB Saunders; 1990. p. 192–201.
Glaser DA, Remlinger K. Blue nails and acquired immunodeficiency syndrome: not always associated with azidothymidine use. Cutis. 1996;57:243.
James CW, McNeils KC, Cohen DM, et al. Recurrent ingrown toenails secondary to indinavir/ritonavir combination therapy. Ann Pharmacother. 2001;35:881–4.
Ward HA, Russo GG, Shrum. Cutaneous manifestations of anti retroviral therapy. J Am Acad Dermatol. 2002;46:284–93.
Cohen PR. The lunula. J Am Acad Dermatol. 1996;34:943.
Leppard B. Blue nails are a sign of HIV infection. Int J STD AIDS. 1999;10:479–82.
Itin PH, Gilli L, Nuesch R, et al. Erythema of the proximal nail fold in HIV-infected patients. J Am Acad Dermatol. 1996;35:631.
Ruiz-Avila P, Tercedor J, Rodenas JM. Periungual erythema in HIV infected patients. J Am Acad Dermatol. 1997;37:1018.
Ruiz-Avila P, Villen A, Rodenas JM. Painful periungual telangiectasia in a patient with acquired immunodeficiency syndrome. Int J Dermatol. 1995;34:199.
Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol. 1989;21:1.
Gisht DB, Singh SS. Pigmented bands on nails: a new sign in malnutrition. Lancet. 1962;i:507.
Maricq HR. Familiar schizophrenia as defined by nail fold capillary pattern and selected psychiatric traits. J Nerv Ment Dis. 1963;136:216.
Maricq HR. Capillary morphology and the course of illness in schizophrenic patients. J Nerv Ment Dis. 1966;142:63.
Maricq HR. Association of a clearly visible subpapillary plexus with other peculiarities of the nail fold skin in some schizophrenic patients. Dermatologica. 1969;138:148.
Patterson JW. Pterygium inversum unguius-like changes in scleroderma. Arch Dermatol. 1977;113:1429.
Goihman-Yahr M. Peculiar dyschromic changes of finger nails in a patient with multiple system atrophy. Int J Dermatol. 1998;37:156–60.
Inglesse M, Haley HR, Elewski BE. Onychotillomania: 2 case reports. Cutis. 2004;73:171–4.
Bensler JM, Paauw DS. Apotemnophilia masquerading as medical morbidity. South Med J. 2003;96:674–6.
Alam M, Moossavi M, Ginsburg I, Scher RK. A psychometric study of patients with nail dystrophies. J Am Acad Dermatol. 2001;45:851–6.
Hediger C, Rost B, Itin P. Cutaneous manifestations in anorexia nervosa. Schweiz Med Wochenschr. 2000;130:565–75.
Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43:1–16.
Marks G, Ellis JP. Yellow nails. Arch Dermatol. 1970;102:619.
Kandil E. Yellow nail syndrome. Int J Dermatol. 1973;12:236.
Pavlidakey GP, Hashimoto K, Blum D. Yellow nail syndrome. J Am Acad Dermatol. 1984;11:509.
Ayres S, Michan R. Yellow nail syndrome, response to vitamin E. Arch Dermatol. 1973;108:267.
Guin JD, Elleman JH. Yellow nail syndrome possible association with malignancy. Arch Dermatol. 1979;115:734.
Decosta SD, Imber MJ, Baden HP. Yellow nail syndrome. J Am Acad Dermatol. 1990;22:608.
Bilen N, et al. Lymphoscintigraphy in yellow nail syndrome. Int J Dermatol. 1998;37:433–53.
Samman PD, White WF. The ‘yellow nail’ syndrome. Br J Dermatol. 1964;76:153.
Burrows NP, Jones RR. Yellow nail syndrome in association with carcinoma of the gall bladder. Clin Exp Dermatol. 1991;16:471.
Moran MF. Upper respiratory problems in the yellow nail syndrome. Clin Otolaryngol. 1976;1:333.
Lodge JP, Hunter AM, Saunders NR. Yellow nail syndrome associated with empyema. Clin Exp Dermatol. 1989;14:328.
Krebs A. Drug-induced nail disorders. Praxis. 1981;70:1951.
Lubach D, Marghescu S. Yellow-nail syndrome <lurch D-enizillamin. Hautzt. 1979;30:547.
Mautner G, Scher RI. Yellow nail syndrome. J Geriatr Dermatol. 1993;1:106.
Ocana I, Bejarno E, Ruiz I, et al. Intestinal lymphangiectasia and the yellow nail syndrome (letter). Gastroenterology. 1988;94:858.
Knuckles MLF, Hodge SJ, et al. Yellow nail syndrome in association with sleep apnea. Int J Dermatol. 1986;25:588.
Meirs HG, Gruel H, Perschmann Y, et al. Yellow nail syndrome. Dtsch Med Wochenschr. 1973;98:1529.
Abell E, Samman PD. Yellow nail syndrome treated by intralesional triamcinolone acetomide. Br J Dermatol. 1973;88:200.
Lebioda. Yellow nail syndrome. Przegl Dermatol. 1972;59:523.
Nelson LM. Yellow nail syndrome. Arch Dermatol. 1969;100:499.
Norton L. Further observations on the yellow nail syndrome with therapeutic effects of oral alphatocopherol. Cutis. 1985;36:457.
Hazebrigg DE, McElroy RJ. The yellow nail syndrome. J Assoc Milit Dermatol. 1980;6:14.
Cohen PR, Prystowsky. Metabolic and nutritional disorders. In: Sams WM, Lynch PJ, editors. Principles and practice of dermatology. New York: Churchill Livingstone; 1996. p. 693–712.
Williams HC, Buffham R, Vivier A. Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome. Arch Dermatol. 1991;127:1023.
Andre J, Walraevens C, DeDoncker P. Yellow nail syndrome infected by dermatophyte SPP: experience with itraconazole pulse treatment combined with vitamin E. Poster exhibit at the annual meeting of the American Academy of Dermatology, New Orleans. 1995.
Cornelius CE, Shelley WB. Shell nail syndrome associated with bronchiectasis. Arch Dermatol. 1967;96:694.
Baran R. Paraneoplastic acrokeratosis of Bazex. Arch Dermatol. 1977;113:1613.
Pecora AL, Landsman L, Imgrund SP, et al. Acrokeratoses paraneoplastics (Bazex’ syndrome). Arch Dermatol. 1983;119:820.
Bazex A, Salvador R, Dupre A. Syndrome paraneoplasique a type d’hyperkeratose des extremities: Guerison apres le traitement de Peoithelioma larynge. Bull Soc Fr Dermatol Syphiligr. 1965;72:182.
Paul SR, Perez-Atayde A, Williams DA. Interstitial pulmonary disease associated with dyskeratosis congenita. Am J Pediatr Hematol Oncol. 1992;14:89.
Lindsay PG. The half and half nail. Arch Intern Med. 1967;119:583.
Bean WB. A discourse on nail growth and unusual fingernails. Trans Am Clin Climatol Assoc. 1963;74:152.
Kint A, Bussels L, Fernandes M, et al. Skin and nail disorders in relation to chronic renal failure. Acta Derm Venereal (Stockh). 1974;54:137.
Nixon DW, Pirozzi D, York RM, et al. Dermatological changes after systemic cancer therapy. Cutis. 1981;27:181.
Daniel CR III. Nail pigmentation abnormalities: an addendum. Cutis. 1982;30:364.
Daniel CR III, Scher RK. Nail changes secondary to systemic drugs and ingestants. J Am Acad Dermatol. 1984;10:250.
Scher RK. Yellow nail syndrome and half -and-half nail. Arch Dermatol. 1987;123:710.
Leyden JJ, Wood MG. The half and half nail. Arch Dermatol. 1972;105:591.
Stewart WK, Raffle EJ. Brown nail bed arcs and chronic renal disease. Br Med J. 1972;1:784.
Bussels L, Kint A, Fernandes M, et al. Lesions cutaneous et unqueales clans l’insuffisance rernile chronique. Arch Belg Dermatol Syphiligr. 1972;28:363.
Gilkes JJH, Eady RAJ, Rees LH, et al. Plasma immunoreactive melanotrophic hormones in patients on maintenance haemodialysis. Br Med J. 1975;1:656.
Lubach D, Strubbe J, Schmidt J. The half and half nail phenomenon in chronic hemodialysis patients. Dermatologica. 1982;164:350.
Levitt JI. Creatine concentration of human fingernail and toenail clippings. Ann Intern Med. 1966;64:312.
Saray Y, Seckin D, Gulec AT, et al. Nail disorders in hemodialysis and renal transplant recipients: a case-control study. J Am Acad Dermatol. 2004;50:197–202.
Tercedor J, Lopez-Hernandez B, Rodenas JM, Serrano S. Nail diseases in hemodialysis patients: case-control study. Poster exhibit from the European Nail Society meeting. 1997.
Kelly MP, Kight MA, Castillo S. Trophic implications of altered body composition observed in or near nails of hemodialysis patients. Adv Ren Transplant Surg. 1998;5:241–51.
Hwang SM, Lee SH, Ahn SK. Pincer nail deformity and pseudo Kaposi’s sarcoma: complications of an artificial arteriovenous fistula for haemodialysis. Br J Dermatol. 1999;141:1129–32.
Sarnow MR, Plotkin EL, Spinosa FA, Cohen R. Nail changes in the seropositive and seronegative arthritides. Clin Podiatr Med Surg. 1989;6:389.
Lugo-Janer G, Sanchez JL, Santiago-Delpin E. Prevalence and clinical spectrum of skin disease in kidney transplant recipients. J Am Acad Dermatol. 1991;24:410.
Maricq HR, Spencer-Green C, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud’s syndrome and dermatomyositis. Am J Med. 1976;61:862.
Minkin W, Rabhan NB. Office nail fold capillary microscopy using ophthalmoscope. J Am Acad Dermatol. 1982;7:190.
Herd JK. Nail fold capillary microscopy made easy. Arthritis Rheum. 1976;19:1370.
Ohtsuka T, et al. Nail fold capillary abnormality and pulmonary hypertension in systemic sclerosis. Int J Dermatol. 1997;36:116–22.
Monticone G, Colonna L, Palermi G, et al. Quantitative nail fold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis and control subjects. J Am Acad Dennatol. 2000;42:787–90.
Poszepczynska-Guigne E, et al. Paraneoplastic acral vascular syndrome. Epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47:47–52.
Fonollosa V, et al. Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosis. Lupus. 2001;10:628–31.
Scher RK, Tom DWK, Lally EV, et al. The clinical significance of PAS-positive deposits in cuticle-proximal nail fold biopsy specimens. Arch Dermatol. 1985;121:1406.
Ohtsuka T, Yamakage A, Tamura T. Image analysis of nail fold capillaries in patients with Raynaud’s phenomenon. Cutis. 1995;56:215.
Mannarino E, Pasqualini L, Fedeli F, et al. Nail fold capillaroscopy in the screening and diagnosis of Raynaud’s phenomenon. Angiology. 1994;45:37–42.
Maricq HR, Maize JC. Nail fold capillary abnormalities. Clin Rheum Dis. 1982;8:45.
Ohtsuka T. The relation between nail fold bleeding and capillary microscopy abnormality in patients with connective tissue diseases. Int J Dermatol. 1998;37:23–6.
Hamilton EBD. Nail studies in rheumatoid arthritis. Ann Rheum Dis. 1960;19:167.
Michel C, et al. Nail abnormalities in rheumatoid arthritis. Br J Dermatol. 1997;137:958–62.
Tosti A. The nail apparatus in collagen disorders. Semin Dermatol. 1991;10:71.
Jaizzo JL, Gonzalez EB, Daniels JC. Red lunulae in a patient with rheumatoid arthritis. J Am Acad Dermatol. 1983;8:711.
Kint A, Herpe LV. Ungual anomalies in lupus erythematosus discoids. Dermatologica. 1976;153:298.
Narehari SR, Srinivas CR, Kelkar SK. LE-like erythema and periungual telangiectasia among coffee plantation workers. Contact Dermatitis. 1990;22:296.
Phelps RG, Fleischrnajer R. Clinical, pathologic, and immuno pathologic manifestations of the toxic oil syndrome. J Am Acad Dermatol. 1988;18:313.
García-Patos, V, Bartralot, R, Ordi, J, Baselga, E, de Moragas, JM, Castells, A. Systemic lupus erythematosus presenting with red lunulae. J Am Acad Dermatol. 1997;36:834–6.
Vaughn RY, Bailey JP, Field RS, et al. Diffuse nail dyschromia in black patients with SLE. J Rheumatol. 1990;17:640.
Skowron R, Combemale P, Faisant M, Baran R. Functional melanonychia due to involvement of the nail matrix in systemic lupus erythematosus. J Am Acad Dermatol. 2002;47:Sl87–188.
Pallis M, Hopkinson N, Powell R. Nail fold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but nor in MLTD. J Rheumatol. 1991;18:1532.
Su WPD, Perniciaro C, Robgers RS, White JW. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis. 1994;53:395.
Thiers BH, Dobson RL. Westwood Western conference on clinical dermatology. J Am Acad Dermatol. 1980;3:651.
Caputo R, Cappio F, Rigorri C, et al. Pterygium inversum unguius. Arch Dermatol. 1993;129:1307.
Norton LA. The nail. Lecture presented at Nail and Hair Symposium sponsored by Columbia University. 1989.
Odom RB, Stein KM, Maibach HI. Congenital painful aberrant hyponychium. Arch Dermatol. 1974;110:89.
Shikano Y, Mori S, Kitajima Y. Detection of scleroderma with capillaroscopic abnormalities of nail folds. Int J Dermatol. 1996;35:857.
Caputo R, Prandi G. Pterygium inversum unguium. Arch Dermatol. 1973;108:817.
Drake L, Goodman TB. Pterygium inversum unguium. Soc Transact Arch Dermatol. 1976;112:255.
Nogira T, Yamashita H, Kawashima M, Hidano A. Pterygium inversum unguis. J Am Acad Dermatol. 1991;24:787.
Fleischmajer R. Unusual nail findings. Lecture presented at the meeting of the American Dermatological Society of Allergy and Immunology, New Orleans. 1980.
Sato S, Takehara K, Sama Y, et al. Diagnostic significance of nail fold bleeding in scleroderma spectrum disorders. J Am Acad Dermatol. 1993;28:198.
Maricq HR. Capillary abnormalities, Raynaud’s phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol. 1992;128:630.
Barrow MV. The nails in multicentric reticulohistiocytosis. Arch Dermatol. 1967;95:200.
Tani M, Hori K, Nakanishi T, et al. Multicentric reticulo – histiocytosis. Arch Dermatol. 1981;117:495.
Sahin AA, Kaloncu AF, Selouk ZT, et al. Behcet’s disease with half and half nail and pulmonary artery aneurysm (letter). Chest. 1990;97:1277.
Greaves MS, Fieller NRJ, Moll JMH. Differentiation between psoriatic arthritis and rheumatoid arthritis: a biochemical and statistical analysis of fingernail amino acids. Scand J Rheumatol. 1979;8:33.
Maeda K, Kawaquchi S, Niwa T, et al. Identification of some abnormal metabolites in psoriasis nail using gas chromatography – mass spectrometry. J Chromatogr. 1980;221:199.
Rasmussen. Childhood psoriasis in pediatric dermatology, dermavision. Videotape presented at the meeting of the American Academy of Dermatology, Evanston, IL. 1982.
Blockmans D, Vermylen J, Babhaers H. Nail fold: I capillaroscopy in connective tissue disorders in Raynaud’s phenomenon. Acta Clin Belg. 1993;48:30.
Gibson GE, Su WPD, Pittlekow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol. 1997;36:970–82.
Chanda JJ, Callen JP. Stevens-Johnson syndrome. Arch Dermatol. 1978;114:626.
Wanscher B, Thormann. Permanent anonychia after Stevens Johnson syndrome. Arch Dermatol. 1977;113:970.
Zaias H. Diseases of the nails. In: Demis J, Dobson RL, Crounse RB, editors. Clinical dermatology. New York: Harper & Row; 1974. p. 1–5.
Wheeler GE, Barrows GH. Alopecia universalis, a manifestation of occult amyloidosis and multiple myeloma. Arch Dermatol. 1981;117:815.
Leavell OW, Farley CH, Mcintyre JS. Cutaneous changes in a patient with carbon monoxide poisoning. Arch Dermatol. 1969;99:429.
Kahn G. Nail involvement in histiocytosis X. Arch Dermatol. 1969;100:699.
Timpatanapong P, Hathirat P, Isarangkura P. Nail involvement in histiocytosis X. Arch Dermatol. 1984;120:1052.
Holzberg M, Wade TR, Buchana ID, et al. Nail pathology in histiocytosis X. J Am Acad Dermatol. 1985;13:522.
Harper JI, Staughton R. Histiocytosis X (letter). Cutis. 1983;31:493.
Chesney PJ, Davis JP, Purdy WK, et al. Clinical manifestations of toxic shock syndrome. JAMA. 1981;246:741.
Niemi KM, Kero M, Kanerva L, et al. Epidermolysis bullosa simplex. Arch Dermatol. 1983;119:138.
Haber RM, Hanna W, Ramsey CA, et al. Hereditary epidermolysis bullosa. J Am Acad Dermatol. 1985;13:252.
Main RA. Periodic shedding of the nails. Br J Dermatol. 1973;88:497.
Palencia SI, Rodrigez-Peralto JL, Castano E, Vanaclocha F, Iglesias L. Lichenoid nail changes as sole external manifestation of graft vs. host disease. Int J Dermatol. 2002;41:44–5.
Fujii K, Kanno Y, Ohgo N. Subungual hyperkeratosis due to sarcoidosis. Int J Dermatol. 1997;36:123–44.
Kalb RE, Grossman ME. Pterygium formation due to sarcoidosis. Arch Dermatol. 1985;121:276.
Wakelin SH, James MP. Sarcoidosis: nail dystrophy with or without underlying bone changes. Cutis. 1995;55:344.
Ahmed I, Cronk JS, Crutchfield CE, Dahl MV. Myeloma-associated systemic amyloidosis presenting as chronic paronychia and palmodigital erythematous swelling and induration of the hands. J Am Acad Dermatol. 2000;42:339–4.
Wong CK, Wang WJ. Systemic amyloidosis: a report of 19 cases. Dermatology. 1994;189:47–51.
Dalziel KL, Telfer NR, Dawber RPR. Nail dystrophy in cutaneous T-cell lymphoma. Br J Dermatol. 1989;120:571.
Wilson AGM, Cotter FE, Lowe DG, et al. Mycosis fungoides in childhood: an unusual presentation. J Am Acad Dermatol. 1991;25:370.
de Berker D, Lever RK, Windebank K. Nail features in Langerhans cell histiocytosis. Br J Dermatol. 1994;130:523–7.
Lynch PJ. Cutaneous signs of systemic malignancy. In: Sams WM, Lynch PJ, editors. Principles and practice of dermatology. New York: Churchill-Livingstone; 1996. p. 739–46.
Parameswara YR, Chinnappaiah RP. Onychomadesis associated with pemphigus vulgaris. Arch Dermatol. 1981;117:759.
Akiyama C, Sou K, Furuya T, et al. Paronychia. A sign heralding an exacerbation of pemphigus vulgaris. J Am Acad Dermatol. 1993;4.
Richards B. A radium fingernail polish. Wall Str J. 1983;72.
Horan MA, Puxty JA, Fox RA. The white nails of old age (neopolitan nails). J Am Geriatr Soc. 1982;30:734.
Fischer VE. Subunguale verkalkungen. Fortschr Rontgenstr. 1982;137:580.
Wong RC, Ellis CN. Physiological skin changes in pregnancy. J Am Acad Dermatol. 1984;10:929.
Hansen U, Haersley T, Knudsen B, Jacobson GK. Erythema elevation diutinum: case report showing an unusual distribution. Cutis. 1994;53:124.
Basuck PJ, Scher RI. Onychomycosis in graft versus host disease. Cutis. 1987;40:237.
Noppakun N, Swasdikul D. Reversible hyperpigmentation of skin and nails with white hair due to vitamin B12 deficiency. Arch Dermatol. 1986;122:896.
Barth JH, Telfer MB, Dawber RPR. Nail abnormalities and autoimmunity. J Am Acad Dermatol. 1988;18:1062.
Wieselthier JAS, Koh HK. Sezary syndrome: diagnosis, prognosis, critical review of options. J Am Acad Dermatol. 1990;22:381.
Tosti A, Fanti PA, Varotti C. Massive lymphomatosis nail involvement in Sezary syndrome. Dermatologica. 1990;181:162.
Simon CA, Su WPD, Chin-Yang L. Subungual leukemia cutis. Int J Dermatol. 1990;29:636.
Lassoued K, Picard C, Danon F, et al. Cutaneous manifestations associated with gamma heavy chain disease. J Am Acad Dermatol. 1990;23:988.
Harrison PV, Khunti K, Morris JA. Psoriatic nails, joints and autoimmunity (letter). Br J Dermatol. 1990;122:569.
Novice F, editor. Handbook of genetic skin disorders. Philadelphia: WB Saunders; 1994.
Yaghmai R, et al. Overlap of dyskeratosis congenital with Hoyeraal-Hreidarsson syndrome. J Pediatr. 2000;136:390–3.
Swensson O. Pachyonychia congenital. Keratin gene mutation with pleiotropic effect. Hautarzt. 1999;50:483–90. [295a]. Bongers EM, Knoers NV. From gene to disease; the nail-patella syndrome and the LMXIB gene. Ned Tijdschr Geneeska. 2003;147(2):67–9.
Bardaro T, et al. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKK gamma gene deletion. Hum Mutat. 2003;21:8–11.
Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dennatol. 2002;47:169–87.
Adeniran A, Townsend PL, Peachey RD. Incontinentia pigmenn (Bloch-Sulzberger syndrome) manifesting as painful periungual and subungual tumors. J Hand Surg (Br). 1993;18:667–9.
Nicolaou N, Graham-Brown RA. Nail dystrophy, an unusual presentation of incontinentia pigmenti. Br J Dermatol. 2003;149:1286–8.
Kumari R, Jaisankar TJ, Thappa DM. A clinical study of skin changes in pregnancy. Indian J Dermatol Venereol Leprol. 2007;73:141.
Rathore SP, Gupta S, Gupta V. Pattern and prevalence of physiological cutaneous changes in pregnancy: a study of 2000 antenatal women. Indian J Dermatol Venereol Leprol. 2011;77(3):402.
Wong RC, Ellis CN. Physiologic skin changes in pregnancy. J Am Acad Dermatol. 1984;10:929–40.
Kroumpouzos G, Scher R. Hair and nail changes. In: Kroumpouzos G, editor. Text atlas of obstetric dermatology. Philadelphia: Lippincott Williams & Wilkins publishers; 2013. p. 39–46.
Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol. 1992;31:375–8.
Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37:429–31.
Ponnapula D, Boberg JS. Lower extremity changes experienced during pregnancy. J Foot Ankle Surg. 2010;49:452–8.
Volterrani M, Rosano G, Coats A, et al. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med. 1995;99:119–22.
Graham-Brown RAC. Physiologic skin changes related to pregnancy. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook/Wilkinson/Ebling textbook of dermatology. 6th ed. London: Blackwell Science; 1998. p. 3269–70.
Hewitt D, Hillman RW. Relation between rate of nail growth in pregnant women and estimated previous general growth rate. Am J Clin Nutr. 1966;19:436–9.
Hillman RW. Fingernail growth in pregnancy: relations to some common parameters of the reproductive process. Hum Biol. 1960;32:119–34.
Block RA, Hess LA, Timpano EV, et al. Physiologic changes in the foot during pregnancy. J Am Podiatr Med Assoc. 1985;75:297–9.
Warraich QA, Cumming GP. Nail deformity in pregnancy. J Obstet Gynaecol. 2004;24:822–3.
Fryer JM, Werth VP. Pregnancy-associated hyperpigmentation: longitudinal melanonychia. J Am Acad Dermatol. 1992;26(3):493–4.
Monteagudo B, Suárez O, Rodríguez I, et al. Longitudinal melanonychia in pregnancy. Actas Dermosifiliogr. 2005;96:550.
Muallem MM, Rubeiz NG. Physiological and biological skin changes in pregnancy. Clin Dermatol. 2006;24:80–3.
Chaudhry SI, Black MM. True transverse leukonychia with spontaneous resolution during pregnancy. Br J Dermatol. 2006;154:1199–219.
Rutnin S, Nguyen JV, Miller CJ, DeHoratius D, Rubin AI. Pregnancy-associated acquired arteriovenous malformation of the nail unit: a novel cause of localized erythronychia. J Cutan Pathol. 2012;39:1030–104.
Lamas CC, Eykyn SJ. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis. 1997;25:713–9.
Silverman ME, Upshaw CB. Extracardiac manifestations of infective endocarditis and their historical descriptions. Am J Cardiol. 2007;100:1802–7.
Ebtia M, Dewa DA. Infective endocarditis revisited: clinical manifestations and echocardiographic findings of patients with infective endocarditis. J Am Coll Cardiol. 2012;59:E1894.
van der Velden HMJ, Klaassen KMG, van de Kerkhof PCM, et al. Fingernail psoriasis reconsidered: a case–control study. J Am Acad Dermatol. 2013;69:245–52.
Sandre MK, Rohekar S, Guenther L. Psoriatic nail changes are associated with clinical outcomes in psoriatic arthritis. J Cutan Med Surg. 2015;19:367–76.
Gisondi P, Idolazzi L, Girolomoni G. Ultrasonography reveals nail thickening in patients with chronic plaque psoriasis. Arch Dermatol Res. 2012;304:727–32.
Belloni B, Schönewolf N, Rozati S, et al. Cutaneous drug eruptions associated with the use of new oncological drugs. Chem Immunol Allergy. 2012;97:191–202.
Autier J, Escudier B, Wechsler J, et al. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol. 2008;144:886–92.
Saladi RN, Persaud AN, Rudikoff D, et al. Idiopathic splinter hemorrhages. J Am Acad Dermatol. 2004;50:289–92.
Hardin J, Haber RM. Onychomadesis: literature review. Br J Dermatol. 2015;172(3):592–6.
Braswell MA, Daniel CR 3rd, Brodell RT. Beau lines, onychomadesis, and retronychia: a unifying hypothesis. J Am Acad Dermatol. 2015;73(5):849–55.
Blomqvist S, Klemola P, Kaijalainen S, et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010;48:49–54.
Zenke, et al. Nail findings in patients with psoriatic arthritis: a cross-sectional study with special reference to transverse grooves. JAAD. 2017;77:863–7.
Yadav TA, Khopkar US. Dermoscopy to detect signs of subclinical nail involvement in chronic plaque psoriasis: a study of 68 patients. Indian J Dermatol. 2015;60(3):272–5.
Walker J, Baran R, Vélez N, Jellinek N. Koilonychia: an update on pathophysiology, differential diagnosis and clinical relevance. J Eur Acad Dermatol Venereol. 2016;30(11):1985–91.
Spicknall KE, Zirwas MJ, English JC. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005;52:1020–8.
Nakamura J, Halliday NA, Fukuba E, Radjenovic A, Tanner SF, Emery P, McGonagle D, Tan AL. The microanatomic basis of finger clubbing – a high-resolution magnetic resonance imaging study. J Rheumatol. 2014;41(3):523–7.
Gold A, Bromberg B, Herbstritt J, Stein H. Digital clubbing: a unique case and a new hypothesis. J Hand Surg Am. 1979;4(1):60–6. https://doi.org/10.1016/S0363-5023(79)80106-9.
Baughman RP, Gunther KL, Buchsbaum JA, Lower EE. Prevalence of digital clubbing in bronchogenic carcinoma by a new digital index. Clin Exp Rheumatol. 1998;16:21–6.
Rutherford JD. Digital clubbing. Circulation. 2013;127:1997–9.
Callemeyn J, Van Haecke P, Peetermans WE, Blockmans D. Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance. Acta Clin Belg. 2016;71(3):123–30.
Kalasekhar V, Venkatesh C. A constellation of nail changes in a child with Kawasaki disease. J Clin Diagn Res. 2015;9(7):SJ01.
Piraccini BM, Rech G, Sisti A, Bellavista S. Twenty nail onychomadesis: an unusual finding in Cronkhite- Canada syndrome. J Am Acad Dermatol. 2010;63(1):172–4.
Prat C, Viñas M, Marcoval J, Jucglà A. Longitudinal melanonychia as the first sign of Addison’s disease. J Am Acad Dermatol. 2008;58(3):522–4.
Sánchez-Moreno EC, Marioni-Manriquez S, Fernández-Martínez RF, Moreno-Coutiño G. Accelerated nail growth rate in HIV patients. Int J Dermatol. 2017;56(5):524–6.
Rahav G, Maayan S. Nail pigmentation associated with zidovudine: a review and report of a case. Scand J Infect Dis. 1992;24(5):557–61.
Jimenez-Gonzalez C, Mata-Marin JA, Arroyo-Anduiza CI, Ascencio-Montiel Ide J, Fuentes-Allen JL, Gaytan-Martinez J. Prevalence and etiology of onychomycosis in the HIV-infected Mexican population. Eur J Dermatol. 2013;23(3):378–81.
Surjushe A, Kamath R, Oberai C, Saple D, Thakre M, Dharmshale S, Gohil A. A clinical and mycological study of onychomycosis in HIV infection. Indian J Dermatol Venereol Leprol. 2007;73(6):397–401.
Zink BS, Valente L, Ortiz B, Caldas A, Jeunon T, Marques-da-Costa J. Periungual Bowen’s disease successfully treated with photodynamic therapy. Photodiagn Photodyn Ther. 2013;10(4):535–7.
Turowski CB, Ross AS, Cusack CA. And Human papillomavirus-associated squamous cell carcinoma of the nail bed in African-American patients. Int J Dermatol. 2009;48(2):117–20.
De D, Dogra S, Narang T, Radotra BD, Kanwar AJ. Pityriasis rubra pilaris in a HIV-positive patient (type 6 PRP). Skinmed. 2008;7(1):47–50.
Bonomo RA, Korman N, Nagashima-Whalen L, Briggs J, Graham R, Salata RA. Review and pityriasis rubra pilaris: an unusual cutaneous complication of AIDS. Am J Med Sci. 1997;314(2):118–21.
Piraccini BM, Urciuoli B, Starace M, Tosti A, Balestri R. Yellow nail syndrome: clinical experience in a series of 21 patients. J Dtsch Dermatol Ges. 2014;12(2):131–7.
Decker A, Daly D, Scher RK. Role of titanium in the development of yellow nail syndrome. Skin Appendage Disord. 2015;1(1):28–30.
Baran R, Thomas L. Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome. J Drug Dermatol. 2009;8(3):276–8.
Corominas H, Ortiz-Santamaría V. Nail fold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatol Int. 2016;36(3):365–9.
Coskun BK. Reiter syndrome accompanied by Terry nail. J Eur Acad Dermatol Venereol. 2005;19(1):87–9.
Figueras-Nart I, Vicente A, Sánchez-Schmidt J, Jou-Muñoz C, Bordas-Orpinell X, Celis-Passini VP, Cruz-Martínez O, González-Ensenyat MA. Langerhans cell histiocytosis presenting as fingernail changes. JAAD Case Rep. 2016;2(6):485–7.
Halteh P, Jorizzo JL, Lipner SR. Darier disease: candy-cane nails and hyperkeratotic papules. Postgrad Med J. 2016;92(1089):425–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
21.1 Electronic Supplementary Materials
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Lipner, S.R., Lawry, M., Kroumpouzos, G., Scher, R.K., Ralph Daniel, C. (2018). Nails in Systemic Disease. In: Rubin, A.I., Jellinek, N.J., Daniel, C.R., Scher, R.K. (eds) Scher and Daniel’s Nails. Springer, Cham. https://doi.org/10.1007/978-3-319-65649-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-65649-6_21
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65647-2
Online ISBN: 978-3-319-65649-6
eBook Packages: MedicineMedicine (R0)